The EmergConnect platform is transforming access to healthcare for Canadians with support from the SOPHIE program.
Allarta Life Science leverages the SOPHIE program with the goal of licensing technology and commercializing treatments.
Making a smart site selection could drive the commercialization of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialization.
Eye3 has gained significant traction including securing financing, developing product concepts and prototypes and filing for patents.
Original Press Release, Yahoo Finance, September 21, 2022 NORTH BRUNSWICK, N.J., Sept. 21, 2022 —
Understanding the common commercialization hurdles mentioned above is one thing, but having the funding and the time to navigate through them is another.
Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.
Learn about how FluidAI Medical’s postoperative monitoring solution is leveraging AI to detect anastomotic leaks and improve recovery times.
Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.
Learn about how FluidAI Medical’s postoperative monitoring solution is leveraging AI to detect anastomotic leaks and improve recovery times.
Learn how Swift Medical is reshaping the way wounds are imaged for diagnosis with AI and data-driven technology.
Discover how Synmedix is combating antibiotic resistance with support from the SOPHIE program and Synapse Life Science Competition.
Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.
Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
Southern Ontario Pharmaceutical & Health Innovation Ecosystem (SOPHIE) Program brings together Innovation Factory’s commercialization services with the Synapse Life Science Consortium’s strategic network to leverage access to Hamilton’s unique life sciences capabilities and research expertise.
